<DOC>
	<DOCNO>NCT00859131</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy induction therapy Thymoglobulin comparison IL2 receptor antagonist ( daclizumab basiliximab ) .</brief_summary>
	<brief_title>Safety Efficacy Study Thymoglobulin Versus IL2 Receptor Antagonists</brief_title>
	<detailed_description>A 12 month , prospective , randomize , single center , open-label study evaluate safety efficacy Rabbit anti-thymocyte globulin versus IL2 receptor antagonists combination tacrolimus , corticosteroid mycophenolate mofetil predominantly high risk kidney transplant population .</detailed_description>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Daclizumab</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Immunoglobulin G</mesh_term>
	<criteria>Male female patient 18 75 year age Male female patient primary repeat cadaveric , live unrelated non Human leukocyte antigen ( HLA ) identical living relate donor renal transplant recipient Female patient child bear potential must negative urine serum pregnancy test within past 48 hour prior study inclusion . The patient give write informed consent participate study Patient previously receive receive organ transplant kidney . Patients recipients multiple organ transplant . Patient receive primary retransplant HLAidentical living donor . Any positive crossmatch . Patient recipient pediatric donor kidney pediatric donor age 8 year less . Patient receive ABO incompatible donor kidney . Recipient donor know seropositive hepatitis C virus ( HCV ) B virus ( HBV ) except hepatitis B surface antibody positive . Recipient donor know seropositive human immunodeficiency virus ( HIV ) . Patient uncontrolled concomitant infection unstable medical condition could interfere study objective . Patients thrombocytopenia ( &lt; 75,000/mm3 ) , absolute neutrophil count &lt; 1,000/mm3 ) ; and/or leucopoenia ( &lt; 2,000/mm3 ) , anemia ( hemoglobin &lt; 6 g/dL ) prior study inclusion . Patient take take investigational drug 30 day prior transplant . Patient known hypersensitivity tacrolimus , mycophenolate mofetil , rabbit antithymocyte globulin , daclizumab corticosteroid . Patients severe diarrhea gastrointestinal disorder might interfere ability absorb oral medication . Patients history malignancy within last five year , except successfully excise squamous basal cell carcinoma skin . Patient pregnant lactating , pregnancy define state female conception termination gestation , confirm positive human Chorionic Gonadotropin ( hCG ) laboratory test . Women childbearing potential must use two reliable form contraception simultaneously , unless status post bilateral tubal ligation , bilateral oophorectomy , hysterectomy . Effective contraception must use begin study drug therapy , duration study 6 week follow completion study . Patient form substance abuse , psychiatric disorder condition , opinion investigator , may invalidate communication investigator . Inability cooperate communicate investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>